文献速递复苏、休克与脓毒症消化、代谢与肾脏急症

基于生物标志物的临床算法推导与验证:急诊入院时从非感染性全身炎症反应综合征中排除脓毒症的多中心前瞻性研究

Derivation and Validation of a Biomarker-Based Clinical Algorithm to Rule Out Sepsis From Noninfectious Systemic Inflammatory Response Syndrome at Emergency Department Admission: A Multicenter Prospective Study.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论多中心前瞻性研究推导并验证了一个基于列线图与生物标志物的算法,可在急诊入院时以93%–100%的阴性预测值排除脓毒症/脓毒性休克,仅需对18%–29%的患者检测生物标志物。

该多中心前瞻性研究在5所大学医院急诊入院成人中,用年龄、SOFA评分、近期抗菌治疗、高热、白细胞增多和高C反应蛋白构建列线图预测感染验前概率,再结合降钙素原等生物标志物组合将患者分类为「可能感染」或「不太可能感染」。推导队列947例(716例感染,120例非感染性SIRS),算法仅需降钙素原并以可溶性磷脂酶A2 IIA组辅助(29%患者检测)即可排除脓毒症/脓毒性休克,阴性预测值93%。验证队列158例中,算法阴性预测值达100%,仅需对18%的人群检测生物标志物。该算法有助于急诊医生鉴别脓毒症/脓毒性休克与非感染性SIRS。

要点

  • 推导队列947例成人中,算法排除脓毒症/脓毒性休克的阴性预测值为93%,仅需对29%的患者检测可溶性磷脂酶A2 IIA组作为降钙素原的补充。
  • 验证队列158例成人中,算法阴性预测值达100%,仅需对18%的人群进行生物标志物检测。
  • 算法先以列线图(年龄、SOFA评分、近期抗菌治疗、高热、白细胞增多、高C反应蛋白)预测感染验前概率,再结合降钙素原等生物标志物组合分类为「可能感染」或「不太可能感染」。
  • 该算法旨在帮助急诊医生在入院时将脓毒症/脓毒性休克与非感染性全身炎症反应综合征区分开。

适用人群与场景

  • 急诊入院成人患者,推导队列947例(716例感染患者,120例非感染性全身炎症反应综合征患者),验证队列185例成人(其中158例纳入验证分析)。
  • 研究在5所大学医院的急诊科入院时进行。

诊断标准与关键阈值

  • 列线图纳入年龄、序贯器官衰竭评估评分、近期抗菌治疗、高热、白细胞增多和高C反应蛋白值,用于预测感染验前概率。
  • 生物标志物组合包括降钙素原、可溶性磷脂酶A2 IIA组、presepsin、可溶性白细胞介素-2受体α和可溶性髓系细胞触发受体-1,用于将患者分类为「可能感染」或「不太可能感染」。

研究设计与关键结果

  • 多中心前瞻性研究,推导队列947例成人(716例感染,120例非感染性SIRS),验证队列185例成人(158例纳入验证分析)。
  • 算法仅需降钙素原并以可溶性磷脂酶A2 IIA组辅助(29%的患者检测),排除脓毒症/脓毒性休克的阴性预测值为93%。
  • 验证队列158例中,算法阴性预测值达100%,仅需对18%的人群检测生物标志物。

证据类型、等级与局限

  • 证据类型:多中心前瞻性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该算法可帮助急诊医生在入院时将脓毒症/脓毒性休克与非感染性全身炎症反应综合征区分开,仅需对部分患者(18%–29%)检测生物标志物。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To derive and validate a predictive algorithm integrating a nomogram-based prediction of the pretest probability of infection with a panel of serum biomarkers, which could robustly differentiate sepsis/septic shock from noninfectious systemic inflammatory response syndrome.

DESIGN: Multicenter prospective study.

SETTING: At emergency department admission in five University hospitals.

PATIENTS: Nine-hundred forty-seven adults in inception cohort and 185 adults in validation cohort.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: A nomogram, including age, Sequential Organ Failure Assessment score, recent antimicrobial therapy, hyperthermia, leukocytosis, and high C-reactive protein values, was built in order to take data from 716 infected patients and 120 patients with noninfectious systemic inflammatory response syndrome to predict pretest probability of infection. Then, the best combination of procalcitonin, soluble phospholipase A2 group IIA, presepsin, soluble interleukin-2 receptor α, and soluble triggering receptor expressed on myeloid cell-1 was applied in order to categorize patients as "likely" or "unlikely" to be infected. The predictive algorithm required only procalcitonin backed up with soluble phospholipase A2 group IIA determined in 29% of the patients to rule out sepsis/septic shock with a negative predictive value of 93%. In a validation cohort of 158 patients, predictive algorithm reached 100% of negative predictive value requiring biomarker measurements in 18% of the population.

CONCLUSIONS: We have developed and validated a high-performing, reproducible, and parsimonious algorithm to assist emergency department physicians in distinguishing sepsis/septic shock from noninfectious systemic inflammatory response syndrome.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Mearelli F, Fiotti N, Giansante C, et al. Derivation and Validation of a Biomarker-Based Clinical Algorithm to Rule Out Sepsis From Noninfectious Systemic Inflammatory Response Syndrome at Emergency Department Admission: A Multicenter Prospective Study. Crit Care Med. 2018. PMID: 29742588. doi:10.1097/CCM.0000000000003206

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。